Top compounds associated with response to OPN1LW


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.3
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.028 0.3
mRNA pac-1 CTRPv2 pan-cancer AAC 0.033 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.029 0.3
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.3
mRNA clofarabine CTRPv2 pan-cancer AAC 0.026 0.3
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.034 0.3
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
Download CSV